Cargando…
贝伐珠单抗联合紫杉醇/卡铂治疗晚期非小细胞肺癌25例分析
BACKGROUND AND OBJECTIVE: The current study reported the result of bevacizumab treatment administered to 25 Chinese patients with advanced non-small cell lung cancer (NSCLC) who were treated at the Peking Union Medical College Hospital as a part of the SAiL (MO19390) trial. This trial is an open, in...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999958/ https://www.ncbi.nlm.nih.gov/pubmed/22237117 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.01.02 |